1 / 15

Sandro Mazzaferro Cattedra di Nefrologia I Facoltà Medicina e Chirurgia

XV Riunione del GdS DDialisi Peritoneale Bari, 19-20 Febbraio 2010. Question Time 2: In DP più vantaggi con la vitamina D o i VDRAs?. Sandro Mazzaferro Cattedra di Nefrologia I Facoltà Medicina e Chirurgia “Sapienza” Università di Roma. Why active Vitamin D therapy in PD .

badrani
Télécharger la présentation

Sandro Mazzaferro Cattedra di Nefrologia I Facoltà Medicina e Chirurgia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. XV Riunione del GdS DDialisi Peritoneale Bari, 19-20 Febbraio 2010 Question Time 2: In DP più vantaggi con la vitamina D o i VDRAs? Sandro Mazzaferro Cattedra di Nefrologia I Facoltà Medicina e Chirurgia “Sapienza” Università di Roma

  2. Why active Vitamin D therapy in PD • To suppress PTH: • But serum Ca Increases (also Ca balance) • But serum P Increases (also P balance) • To improve morbidity/mortality: • Linked to SH (bone disease/fractures and toxicity) • Linked to CV effects of CKD-MBD

  3. Bushinsky CJASN 2010

  4. Structures of Calcitriol and Paricalcitol CH3 H3C H3C CH3 CH3 OH OH CH3 CH3 Induzione VDR Intestino _ + CH2 Ca e P da Osso _ + HO HO OH OH 19-nor-1-a, 25-dihydroxyvitamin D2 1-a, 25-dihydroxyvitamin D3 Paricalcitol Calcitriol

  5. The Effects of 1,25-(OH)2D3 and 19-nor-1,25-(OH)2D2on Ionized Calcium in Uremic Rats 6.00 * = p<0.02 5.50 * 5.00 Ionized Calcium (mg/dL) 4.50 4.00 UREMIC N 0 2 4 8 8 25 75 ng 1.25-(OH)2D3 19-nor-1,25(OH)2D2 Slatopolsky AJKD 1995

  6. Effects of 1,25D-(OH)2D3 and 19-Nor-1,25-(OH)2D2 on Intestinal 1,25-(OH)2D3–VDR Binding in Uremic Rats *p<0.01 vs Uremic+1,25D-6ng (fmol/mg protein) 3H-1,25-(OH)2D3 Specific Binding * * * Uremic ng 0 2 6 25 100 Normal 1,25-(OH)2D3 19-nor-1,25-(OH)2D2 Slatopolsky AJKD 1995

  7. Dose-dependent Effects of 1,25D3 and 19-norD2 on Osteoclastic Resorption: Area Resorbed 120 1,25D3 100 19-norD2 80 Area Resorbed, % 108 1,25D3 60 40 20 0 10-11 10-10 10-9 10-8 10-7 10-6 Concentration, M Holliday S, JASN 11:1857, 2000

  8. Dose-dependent Effects of 1,25D3 and 19-norD2on Osteoclastic Resorption: Number of Pits 120 1,25D3 100 19-norD2 80 Number of Pits, % 10-8 1,25D3 60 40 20 0 1011 1010 109 108 107 106 Concentration, M Holliday S, JASN 11:1857, 2000

  9. Serum Calcium and Phosphorus in Placebo and Paricalcitol Treated Patients Placebo Paricalcitol 11 10 Calcium 9 8 7 6 Phosphorus Serum Calcium or Phosphorus mg/dl 5 4 3 2 1 0 1 2 3 4 5 6 7 8 9 10 11 12 Weeks Martin et al. JASN 9: 1427, 1998

  10. Lund et al Am J Neph, 2010Intestinal Ca Absorption in HD: comparison between Calcitriol and Paricalcitol 22 HD pts; PTH>200pg/ml Calcitriol i.v.; 2ug/HDx6 Paricalcitol i.v.; 6 ug/HDx6

  11. Potential advantages of Paricalcitol vs Calcitriol • PTH suppression with: • Lower calcemic effect; • Lower phosphate effect; • Better survival To date no RCT is available to clearly demonstrate the last statement.

  12. Sanchez NDT 2004 Low vs standard CaD in PD Not all ABD! CaD = 1,75 M CaD = 1,25 M 1 Year!

  13. PTH TCa OC No change!! Ca++ Mg P

More Related